This study is for people with blood cancers like leukemia or lymphoma who have had a stem cell transplant or cell therapy. It tests a new COVID-19 vaccine (GEO-CM04S1) to see if it provides better protection against COVID-19 than the standard mRNA vaccines. The goal is to help th…
Phase: PHASE2 • Sponsor: GeoVax, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC